United States · FDA National Drug Code directory
Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58602-703_36996eb4-9195-4bfc-a687-fdb4ea05a860
- Product NDC
- 58602-703
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride
- Labeler
- Aurohealth LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230308
- Source listing expiry
- 20271231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 5 mg/1
- PSEUDOEPHEDRINE HYDROCHLORIDE — 120 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 12 BLISTER PACK in 1 CARTON (58602-703-09) / 2 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · 58602-703-09
- 12 BLISTER PACK in 1 CARTON (58602-703-53) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · 58602-703-53
- 2 BLISTER PACK in 1 CARTON (58602-703-75) / 6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · 58602-703-75
- 4 BLISTER PACK in 1 CARTON (58602-703-76) / 6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · 58602-703-76
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →